Blog
RSS FeedPosted by Michael Wonder on 25 Feb 2018
Terminal cancer patient denied access to life-extending chemo drug
25 February 2018 - A chemotherapy drug called Velcade made Dan Gaffney's death from terminal cancer seem a little further ...
Posted by Michael Wonder on 19 Feb 2018
A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma
13 February 2018 - Australian Government subsidisation of ipilimumab for the treatment of patients with metastatic melanoma was conditional on the ...
Posted by Michael Wonder on 19 Feb 2018
August 2018 PBAC special meeting
19 February 2018 - Options for listing of pan-tumour indications for PDL-1 cancer immunotherapies on the PBS. ...
Posted by Michael Wonder on 18 Feb 2018
Win for cancer patients may be end to chemotherapy as immunotherapies fast-tracked
19 February 2018 - Chemotherapy could become a thing of the past for up to two in three cancer patients ...
Posted by Michael Wonder on 02 Jan 2018
Schedule of Pharmaceutical Benefits - 1 January 2018 update
1 January 2018 - The January 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Dec 2017
Two cancer-fighting medicines listed on the PBS and now accessible to Australians
30 December 2017 - Medications that can inhibit the growth of two "catastrophic cancers" will next week be made available ...
Posted by Michael Wonder on 30 Dec 2017
Multiple myeloma drug carfilzomib added to PBS
29 December 2017 - A new cancer drug that could drastically extend the life of up to 1700 Australians a ...
Posted by Michael Wonder on 10 Dec 2017
Rare cancer treatment a success for Jie Eccles
9 December 2017 - Six months ago Jie wrote an open letter to the readers of news.com.au asking them to help ...
Posted by Michael Wonder on 05 Dec 2017
The Webster family spent their life savings to save their son Matthew after rare cancer diagnosis
3 December 2017 - When David and Jennifer Webster’s son Matthew was diagnosed with a rare cancer, they didn’t think ...
Posted by Michael Wonder on 01 Dec 2017
Continuing to make new medicines affordable for Australians
1 December 2017 - A new medicine to treat soft tissue sarcoma will be available through the Pharmaceutical Benefits Scheme, giving ...
Posted by Michael Wonder on 30 Nov 2017
Schedule of Pharmaceutical Benefits - 1 December 2017 update
1 December 2017 - The December 2017 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Nov 2017
Prioritise investment in the PBS to improve access to all cancer medicines
30 November 2017 - Medicines Australia response to the Senate Select Committee report “Funding for Research into Cancers with Low ...
Posted by Michael Wonder on 27 Nov 2017
We don’t need to change how we subsidise ‘breakthrough’ cancer treatments
27 November 2017 - New therapies that arm the immune system to fight cancer, such as Keytruda (pembrolizumab) and Yervoy ...
Posted by Michael Wonder on 22 Nov 2017
'Are you scared of dying, dad?': the constant uncertainty of immunotherapy
22 November 2017 - An intense feeling of foreboding would seize Ian Cant every three months. ...
Posted by Michael Wonder on 22 Nov 2017
Chemotherapy compounder ID mandatory within PBS claims from 1 December 2017
22 November 2017 - From 1 December 2017, approved suppliers (approved pharmacists, approved medical practitioners and approved public and private ...